Find information on thousands of medical conditions and prescription drugs.

Itraconazole


Itraconazole (marketed as Sporanox® by Janssen Pharmaceutica) is an antifungal agent that is prescribed to patients with fungal infections. The drug may be given orally or intravenously. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
Ibuprofen
Idarubicin
Idebenone
IFEX
Iloprost
Imatinib mesylate
Imdur
Imipenem
Imipramine
Imiquimod
Imitrex
Imodium
Indahexal
Indapamide
Inderal
Indocin
Indometacin
Infliximab
INH
Inosine
Intal
Interferon gamma
Intralipid
Invanz
Invirase
Iontocaine
Iotrolan
Ipratropium bromide
Iproniazid
Irbesartan
Iressa
Irinotecan
Isocarboxazid
Isoflurane
Isohexal
Isoleucine
Isomonit
Isoniazid
Isoprenaline
Isordil
Isosorbide
Isosorbide dinitrate
Isosorbide mononitrate
Isotretinoin
Itraconazole
Ivermectin
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Pharmacology

The mechanism of action of itraconazole is the same as the other azole antifungals: it inhibits cytochrome P450 oxidase mediated sysnthesis of ergosterol.

Indication

Itraconazole has a broader spectrum of activity than fluconazole (but not as broad as voriconazole or posaconazole). In particular, it is active against aspergillus, which fluconazole is not. It is also licenced for use in blastomycosis, histoplasmosis and onychomycosis.

Dosing

Itraconazole is available as capsules or as an oral solution. The dose is 200mg once a day, to 400mg in severe infection. There is an intravenous preparation available in the US, but not in the UK. In the UK, if an intravenous preparation is required, then an alternative antifungal drug should be used.

The main problem with the use of itraconazole is its poor absorption, especially when given in capsule form. The oral solution is much better absorbed and should always be used in preference to the capsule. The cyclodextrin contained in the oral solution can cause an osmotic diarrhoea, and if this is a problem, then half the dose can be given as oral solution and half as capsule in order to reduce the amount of cyclodextrin given. Itraconazole capsules should always be taken with food, as this improves absorption. Itraconazole oral solution should be taken an hour before food, or two hours after food (and likewise if a combination of capsules and oral solution are used). Itraconazole should be taken with orange juice or cola, as absorption is also improved by acid. Absorption of itraconazole is impaired when taken with an antacid, H2-blocker or proton pump inhibitor.

In life-threatening situations, some doctors give an oral loading dose of 200mg three times a day for three days, before dropping down to the usual dose. Because itraconazole absorption is unreliable, blood levels should be monitored at least once a week in those patients who are being treated for life-threatening (or potentially life-threatening) fungal infections.

In intravenous dosing, four doses of itraconazole 200mg are given 12 hours apart, before changing the dose to once daily. There is no safety data for giving the intravenous preparation for more than 14 days continuously.

Adverse effects

Itraconazole is a relatively well tolerated drug (although not as well tolerated as fluconazole or voriconazole) and the range of adverse effects it produces is similar to the other azole antifungals.

  • Elevated alanine aminotransferase levels is found in 4% of people taking itraconazole
  • Congestive Heart Failure

The cyclodextrin that is used to make the syrup preparation can cause diarrhoea.

Read more at Wikipedia.org


[List your site here Free!]


Single pulse dose of itraconazole effective in the treatment of tinea pedis - Washington Whispers - Author Abstract
From Journal of Drugs in Dermatology, 8/1/03

This study was conducted to evaluate the efficacy and safety of single pulse dosing of itraconazole in the treatment of tinea pedis. This was an open-design, prospective, non-comparative study which involved initially 58 patients, of whom only 44 finished all phases of the study and met all criteria. All of them had clinically and mycologically proven interdigital or mild hyperkeratotic tinea pedis without onychomycosis. Patients were given 200 mg itraconazole, twice daily, for a total of seven days. Patients were evaluated at baseline, immediately following treatment, 30 days, and 60 days following treatment.

T. rubrum was isolated from 93% of the patients, with T. interdigitale the second most commonly found organism. At 60 days following treatment, there were 2 (4.5%) failures (few clinical changes and positive KOH/culture), 5 (11.3%) improvements (clinical changes and positive KOH), and 37 (84.4%) cures (clinical and mycologic). Three adverse events were reported: one moderate headache and two moderate dyspepsias.

Bonifaz A et al. Treatment of tinea pedis with a single pulse of itraconazole. Eur J Dermatol 2002; 12:157-59.

COPYRIGHT 2003 Journal of Drugs in Dermatology
COPYRIGHT 2003 Gale Group

Return to Itraconazole
Home Contact Resources Exchange Links ebay